Toll-like receptor 4 antagonist and obesity associated kidney disease: Where should we go from here?.
10.1016/j.krcp.2014.10.007
- Author:
Quaisar ALI
1
Author Information
1. BMSB 662, Department of Physiology, University of Oklahoma Health Sciences Center, 940 Stanton L. Young Blvd., Oklahoma City, OK 73104, USA. quaisar-ali@ouhsc.edu
- Publication Type:Letter
- MeSH:
Kidney Diseases*;
Obesity*;
Toll-Like Receptor 4*
- From:Kidney Research and Clinical Practice
2015;34(1):64-65
- CountryRepublic of Korea
- Language:English
-
Abstract:
No abstract available.
